Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study.
Wang Q, Guo H, Li Y, Jian X, Hou X, Zhong N, Fei J, Su D, Bian Z, Zhang Y, Hu Y, Sun Y, Yu X, Li Y, Jiang B, Li Y, Qin F, Wu Y, Gao Y, Hu Z.
Wang Q, et al.
Front Pharmacol. 2021 Jul 2;12:581833. doi: 10.3389/fphar.2021.581833. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34276351
Free PMC article.